Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms.

Chen, Bi-Lian

Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms. [electronic resource] - Clinical and experimental pharmacology & physiology Aug 2008 - 904-8 p. digital

Publication Type: Journal Article

1440-1681

10.1111/j.1440-1681.2008.04915.x doi


Adenosine Diphosphate--pharmacology
Adult
Aryl Hydrocarbon Hydroxylases--genetics
Clopidogrel
Cytochrome P-450 CYP2C19
Genotype
Humans
Male
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Polymorphism, Genetic
Ticlopidine--analogs & derivatives